Erik Sokolowski

Bio:

Erik Sokolowski is a seasoned Clinical Operations leader with more than 20 years of experience spanning clinical development, medical affairs, patient advocacy, and end‑to‑end trial execution across both rare and prevalent diseases. He is known for building high‑performing teams, advancing operational governance, and delivering clinical programs that meet the highest standards of quality, compliance, and patient focus. His leadership is grounded in integrating real‑world patient and healthcare insights to guide development strategy and improve trial outcomes.

Erik currently serves as Head of Clinical Operations and Development at Zevra Therapeutics, where he oversees clinical program execution, strategic vendor partnerships, and initiatives that expand patient access to investigational therapies through Early Access Programs. In this role, he drives operational strategy, supports portfolio decision‑making, and ensures disciplined execution across Zevra’s development pipeline. Prior to joining Zevra, Erik spent a decade at Alnylam Pharmaceuticals in senior Clinical Operations and Medical Affairs roles. Most recently, he served as Head of Global Trial Optimization, leading enterprise‑level initiatives to accelerate study start‑up, enhance patient recruitment and feasibility strategies, and strengthen cross‑functional governance to support high‑quality global trials. Erik began his career at Genzyme/Sanofi, where he held progressively senior roles over eleven years and built foundational expertise in rare disease clinical development.